MedPath

Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS)

Not Applicable
Completed
Conditions
Traumatic Brain Injury
Word Finding Difficulty
Acquired Brain Injury
Cognitive Change
Interventions
Device: Active Transcranial direct current stimulation
Device: Sham Transcranial direct current stimulation
Registration Number
NCT05408975
Lead Sponsor
The University of Texas at Dallas
Brief Summary

The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area) thought to aid in memory will improve verbal retrieval in civilian (non-military, non-veteran) participants with histories of traumatic brain injuries. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition, concussion history, structural brain imaging, and EEG predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.

Detailed Description

Using two treatment arms, the study will examine improvement of verbal retrieval and other cognitive deficits associated with remote traumatic brain injury by comparing (1) 1 milliamp transcranial direct current stimulation (tDCS) active treatment applied to presupplementary motor area for 20 minutes over 10 sessions to (2) sham tDCS following the same schedule. Additionally, after completing the initial active or sham treatment and 2-month follow-up testing sessions, participants will be invited back for newly assigned treatment conditions, 20 minutes over 10 sessions and will be re-evaluated at 2-months follow-up testing sessions.

Civilians with histories of traumatic brain injuries and observed cognitive deficits will be randomly assigned to one of the two treatment arms (and re-assigned for the second round of intervention, as described above). Primary outcome verbal retrieval measures, secondary neuropsychological and electroencephalography (EEG) measures, and prescreening assessments for study concussion history and contraindications for treatment will be collected prior to being assigned to a treatment arm (i.e., baseline). Magnetic resonance imaging of the brain will be obtained only at the baseline assessment.

Primary outcome verbal retrieval measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected after treatment session 10 and one time following treatment competition (i.e., 2-months). For participants who complete the second round of intervention, primary outcome verbal memory measures and secondary neuropsychological and electroencephalography (EEG) measures will be collected again after treatment session 10 and one time following competition of the second treatment (i.e., 2-months).

This study was funded by NIH/NIDCD under grant number \[1K99DC020185\]. Federal funding concluded on 11/30/2024.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria

Participants are to be between the ages of 18-85, are non-military personnel and not veterans, and have had a traumatic brain injury (more than a year ago prior to study participation) that has led to a complaint of word finding difficulty since the brain injury, confirmed to represent a verbal retrieval deficit based on neuropsychological testing criteria. Traumatic brain injury must be in the mild to moderate range based on evaluation, including the Ohio State TBI Identification Method (administered by our research group). You must be fluent in speaking and reading English.

Exclusion Criteria
  • an implanted/electronic device, such as a pacemaker, metallic cranial or intracranial implant (e.g., ventriculoperitoneal shunt), or a neurostimulator (e.g., vagus nerve stimulator, spinal stimulator, deep brain stimulator, etc.).
  • skull defects
  • a history of a psychological or neurological disorder, including, dementia of any type, epilepsy or other seizure disorders, post-traumatic stress disorder, brain tumor, present drug abuse, stroke, blood vessel abnormalities in the brain, Parkinson's disease, Huntington's disease, or multiple sclerosis.
  • inability to give informed consent
  • currently pregnant
  • not a native English speaker

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Active to Sham Transcranial direct current stimulationSham Transcranial direct current stimulationSubjects in this arm will first be randomly assigned to receive active stimulation. After completion of active stimulation, subjects will be assigned to sham stimulation.
Active to Sham Transcranial direct current stimulationActive Transcranial direct current stimulationSubjects in this arm will first be randomly assigned to receive active stimulation. After completion of active stimulation, subjects will be assigned to sham stimulation.
Sham to Active transcranial direct current stimulationActive Transcranial direct current stimulationSubjects in this arm will first be randomly assigned to receive sham stimulation. After completion of sham stimulation, subjects will be assigned to active stimulation.
Sham to Active transcranial direct current stimulationSham Transcranial direct current stimulationSubjects in this arm will first be randomly assigned to receive sham stimulation. After completion of sham stimulation, subjects will be assigned to active stimulation.
Primary Outcome Measures
NameTimeMethod
The Controlled Oral Word Association TestTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Control Word Association Test. Metric: Number of Correct Items Generated

Category FluencyTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on Category Fluency. Metric: Number of Correct Items Generated

Rey Auditory Verbal Learning Test and alternative listsTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change in Rey Auditory Verbal Learning Test. Metric: Number of Total learning items and Correct Recalls.

The Boston Naming TestTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on The Boston Naming Test. Metric: Number of Correct Items Generated.

Semantic Object Retrieval TestTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change in Semantic Object Retrieval Test. Metric: Number of Correct Retrievals.

The Delis Kaplan Color Word Interference TestTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Delis Kaplan Color Word Interference Test. Metric: Time to Name Items

Secondary Outcome Measures
NameTimeMethod
The Trail Making Test (Parts A & B)Treatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Trail Making Test (Parts A\&B). Metric: Time to Solution

Digit Span Forward & BackwardTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change in Digit Span Forward \& Backward. Metric: Memory Span

The Digit Symbol Substitution TestTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change on the Digit Symbol Substitution Test. Metric: Number of Items

Task-based electroencephalography (EEG) markers during a Go-NoGo taskTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in EEG change on a Go-NoGo task with different levels of perceptual/semantic complexity. Metric: event-related potentials and time frequency changes.

Rey-Osterrieth Complex Figure TestTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in change in Rey-Osterrieth Complex Figure Test scores. Metric: Score

Task-based electroencephalography (EEG) markers during a Semantic Object Memory Retrieval taskTreatment differences (active versus sham) in change from Baseline to immediately and 2-months Post-Treatment.

Evaluation of treatment differences (active versus sham) in EEG change on a Semantic Object Retrieval task. Metric: event-related potentials and time frequency changes.

Trial Locations

Locations (2)

The University of Texas at Dallas

🇺🇸

Dallas, Texas, United States

University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath